Paradigm Biocapital Advisors LP
Insider Reports History
- Location
- New York, NY
- Signature
- /s/ David Kim, as an authorized signatory of the Fund and the Adviser GP (for itself and on behalf of the Adviser)
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Paradigm Biocapital Advisors LP:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Olema Pharmaceuticals, Inc. | 10%+ Owner | Common Stock, par value $0.0001 per share | 6,590,981 | $76,455,380 | $11.60 | 06 Dec 2023 | By: Paradigm BioCapital International Fund Ltd. |
| Olema Pharmaceuticals, Inc. | 10%+ Owner | Common Stock, par value $0.0001 per share | 4,720,482 | $70,405,989 | $14.92 | 01 Aug 2024 | By: Paradigm BioCapital International Fund Ltd. |
| Olema Pharmaceuticals, Inc. | 10%+ Owner | Common Stock, par value $0.0001 per share | 1,312,619 | $15,226,380 | $11.60 | 06 Dec 2023 | By: One or more separately managed accounts |
| Olema Pharmaceuticals, Inc. | 10%+ Owner | Common Stock, par value $0.0001 per share | 783,118 | $11,680,205 | $14.92 | 01 Aug 2024 | By: One or more separately managed accounts |
Insider Reports Filed by Paradigm Biocapital Advisors LP
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OLMA | Olema Pharmaceuticals, Inc. | 01 Aug 2024 | 2 | -$35,796,000 | 4 | 10%+ Owner | 05 Aug 2024, 16:30 |
| OLMA | Olema Pharmaceuticals, Inc. | 06 Dec 2023 | 1 | +$1,160,000 | 4 | 10%+ Owner | 08 Dec 2023, 16:19 |
| OLMA | Olema Pharmaceuticals, Inc. | 12 Sep 2023 | 0 | $0 | 3 | 10%+ Owner | 21 Sep 2023, 17:12 |